Use of T-cell antibodies for donor dosaging in a canine model of in utero hematopoietic stem cell transplantation

Fetal Diagnosis and Therapy

Volumn 22, Issue 3, 2007, Pages 175-179

  Petersen, Scott M ^a,b   Gendelman, Mariya ^a   Murphy, Kathleen M ^a   Torbenson, Michael ^a   Jones, Richard J ^a   Althaus, Janyne E ^a   Stetten, Gail ^a   Bird, Chris ^a   Blakemore, Karin J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Bone marrow transplantation; Canine model; Hematopoietic stem cell

Indexed keywords

T LYMPHOCYTE ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANIDAE; CD34 SELECTION; CHIMERA; CONTROLLED STUDY; DONOR; DRUG DOSE REGIMEN; ECHOGRAPHY; FEMALE; FETUS; GESTATIONAL AGE; GRAFT VERSUS HOST REACTION; HISTOLOGY; HISTOPATHOLOGY; IN UTERO STEM CELL TRANSPLANTATION; MALE; MICROCHIMERISM; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SURVIVAL;

ANIMALS; ANIMALS, NEWBORN; ANTILYMPHOCYTE SERUM; BASE SEQUENCE; DNA PRIMERS; DOGS; FEMALE; FETAL THERAPIES; FETAL TISSUE TRANSPLANTATION; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MALE; MODELS, ANIMAL; PREGNANCY; T-LYMPHOCYTES; TISSUE DONORS; TRANSPLANTATION CHIMERA;

EID: 34247141337     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098711     Document Type: Article

References (18)

1. Flake AW, Zanjani ED: In utero hematopoietic stem cell transplantation: a status report. JAMA 1997;278:932-937.
2. Flake AW, Roncarolo MG, Puck JM, Almeida-Porada G, Evans MI, Johnson MP, Abella EM, Harrison DD, Zanjani ED: Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. N Engl J Med 1996;335:1806-1810.
3. Wengler GS, Lanfranchi A, Frusca T, Verardi R, Neva A, Brugnoni D, Giliani S, Fiorini M, Mella P, Guandalini F, Mazzolari E, Pecorelli S, Notarangelo LD, Porta F, Ugazio AG: Inutero transplantation of parental CD34 haematopoietic progenitor cells in a patient with X-linked severe combined immunodeficiency (SCIDXI). Lancet 1996;348:1484-1487.
4. Crombleholme TM, Harrison MR, Zanjani ED: In utero transplantation of hematopoietic stem cells in sheep: the role of T cells in engraftment and graft-versus-host disease. J Pediatr Surg 1990;25:885-892.
5. Shields LE, Gaur LK, Gough M, Potter J, Sieverkropp A, Andrews RG: In utero hematopoietic stem cell transplantation in nonhuman primates: the role of T cells. Stem Cells 2003;21:304-314.
6. Blakemore K, Hattenburg C, Stetten G, Berg K, South S, Murphy K, Jones R: In utero hematopoietic stem cell transplantation with haploidentical donor adult bone marrow in a canine model. Am J Obstet Gynecol 2004;190:960-973.
7. Ostrander EA, Sprague GF Jr, Rine J: Identification and characterization of dinucleotide repeat (CA)n markers for genetic mapping in dog. Genomics 1993;16:207-213.
8. Andersen AC, Goldman M: Growth and development; in Andersen AC, Good LS (eds): The Beagle as an Experimental Dog. Ames (Iowa), The Iowas State University Press, 1970, pp 43-52.
9. Yeager AE, Mohammed HO, Meyers-Wallen V, Vannerson L, Concannon PW: Ultrasonographic appearance of the uterus, placenta, fetus, and fetal membranes throughout accurately timed pregnancy in beagles. Am J Vet Res 1992;53:342-351.
10. Tyan ML: Modification of severe graft vs. host disease with antisera to the pheta antigen or to whole serum. Transplantation 1973;15:601-604.
11. Prentice HG, Janossy G, Price-Jones L, et al: Depletion of T-lymphocytes in donor marrow prevents significant graft versus host disease in matched allogeneic leukaemic marrow transplant recipients. Lancet 1983;1:472-478.
12. Hakim FT and Mackall CL: The immune system: effector and target of graft-versushost disease; in Ferrara JLM, Deeg HJ, Burakoff SJ (eds): Graft-vs.-Host Disease, ed 2, Revised and Expanded. New York, NY, Marcel Dekker, Inc., 1997, p 260.
13. Patterson J, Prentice HG, Brenner MK, Gilmore M, Janossy G, Ivory K, Skeggs D, Morgan H, Lord J, Blacklock HA: Graft rejection following HLA matched T-lymphocyte depleted bone marrow transplantation. Br J Haematol 1986;63:221-230.
14. Martin PJ, Hansen JA, Torok-Storb B, Durnam D, Przepiorka D, O'Quigley J, et al: Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants. Bone Marrow Transplant 1988;3:445-452.
15. Zanjani ED, Ascensao JL, Flake AW, Harrison MR, Tavassoli M: The fetus as an optimal donor and recipient of hemopoietic stem cells. Bone Marrow Transplant 1992;10:107-114.
16. Zanjani ED, Ascensao JL, Tavassoli M: Homing of liver-derived hemopoietic stem cells to fetal bone marrow. Trans Assoc Am Physicians 1992;105:7-14.
17. Ostrander EA, Galibert F, Patterson DF: Canine genetics comes of age. Trends Genet 2000;16:117-124.
18. McSweeney PA, Rouleau KA, Storb R, Bolles L, Wallace PM, Beauchamp M, Krizanac-Bengez L, Moore P, Sale G, Sandmaier B, de Revel T, Appelbaum FR, Nash RA: Canine CD34: cloning of the cDNA and evaluation of an antiserum to recombinant protein. Blood 1996;88:1992-2003.